Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Qatar.
Campus
Campus

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
How does Dupixent help recover smell?

How does Dupixent help recover smell?

Learn more
New 2022 ADA/EASD Guidelines: GLPP-1 RA/Insulin Combination Is Recommended

New 2022 ADA/EASD Guidelines: GLPP-1 RA/Insulin Combination Is Recommended

ADA/EASD recommend considering combination injectables therapy of basal insulin/GLP-1 RA (Such as Soliqua®) as valuable treatment option to provide adequate efficacy for achieving and maintaining glycemic goals.

Learn more
Inspiring Stories of Patients Living with ASMD

Inspiring Stories of Patients Living with ASMD

Learn more
Their Stories shaped them like Pearls

Their Stories shaped them like Pearls

Learn more
Post-exercise hypoglycemia in relation to medication regimen among adults with type 2 diabetes

Post-exercise hypoglycemia in relation to medication regimen among adults with type 2 diabetes

Learn more
What Is Time-in-Range?

What Is Time-in-Range?

Learn more
The Role of Pediatrician in Gaucher Disease

The Role of Pediatrician in Gaucher Disease

Learn more
ASMD Phenotypes

ASMD Phenotypes

Learn more
Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control

Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control

Learn more
Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs

Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs

Learn more
ADA 2021: Solimix Trial Summary

ADA 2021: Solimix Trial Summary

Learn more
Regulate LDL-C level for those undergoing coronary revascularization (Diabetic Patients)

Regulate LDL-C level for those undergoing coronary revascularization (Diabetic Patients)

Learn more